CN122520749A - 优化的gip肽类似物 - Google Patents
优化的gip肽类似物Info
- Publication number
- CN122520749A CN122520749A CN202610465590.8A CN202610465590A CN122520749A CN 122520749 A CN122520749 A CN 122520749A CN 202610465590 A CN202610465590 A CN 202610465590A CN 122520749 A CN122520749 A CN 122520749A
- Authority
- CN
- China
- Prior art keywords
- gip
- seq
- amino acid
- peptide
- a13aib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/645—Secretins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2019/083506 | 2019-12-03 | ||
| PCT/EP2019/083506 WO2020115048A1 (en) | 2018-12-03 | 2019-12-03 | Modified gip peptide analogues |
| EP20179259 | 2020-06-10 | ||
| EP20179259.5 | 2020-06-10 | ||
| PCT/EP2020/084487 WO2021110845A1 (en) | 2019-12-03 | 2020-12-03 | Optimized gip peptide analogues |
| CN202080083881.1A CN114761420B (zh) | 2019-12-03 | 2020-12-03 | 优化的gip肽类似物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080083881.1A Division CN114761420B (zh) | 2019-12-03 | 2020-12-03 | 优化的gip肽类似物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN122520749A true CN122520749A (zh) | 2026-08-07 |
Family
ID=71083547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202610465590.8A Pending CN122520749A (zh) | 2019-12-03 | 2020-12-03 | 优化的gip肽类似物 |
| CN202080083881.1A Active CN114761420B (zh) | 2019-12-03 | 2020-12-03 | 优化的gip肽类似物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080083881.1A Active CN114761420B (zh) | 2019-12-03 | 2020-12-03 | 优化的gip肽类似物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250346647A2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4069719A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7788376B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220108064A (cg-RX-API-DMAC7.html) |
| CN (2) | CN122520749A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020398675A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3157387A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL293249A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006737A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021110845A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023014740A (es) * | 2021-06-10 | 2024-03-13 | Antag Therapeutics Aps | Tratamiento de la obesidad y trastornos relacionados con la obesidad. |
| WO2023139106A2 (en) * | 2022-01-18 | 2023-07-27 | Novo Nordisk A/S | Long-acting gipr antagonists |
| CN117402219B (zh) | 2022-07-13 | 2024-07-30 | 杭州中美华东制药有限公司 | Glp-1/gip双激动剂及其制备方法和用途 |
| AR134436A1 (es) * | 2023-11-22 | 2026-01-14 | Hangzhou Zhongmeihuadong Pharmaceutical Co Ltd | Uso de un agonista dual glp-1r / gipr en la fabricación de un medicamento veterinario |
| TW202615088A (zh) * | 2024-06-14 | 2026-04-16 | 美商美國禮來大藥廠 | 用於改善胰島素敏感性之組合物及方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101155828A (zh) * | 2005-02-11 | 2008-04-02 | 安米林药品公司 | Gip类似物和具有可选择性质的杂合多肽 |
| US8263545B2 (en) * | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| CA2597649A1 (en) * | 2005-02-11 | 2006-08-17 | Amylin Pharmaceuticals, Inc. | Gip analog and hybrid polypeptides with selectable properties |
| JP5399244B2 (ja) * | 2006-08-17 | 2014-01-29 | アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | 選択可能な特性を持つdpp−iv耐性gipハイブリッドポリペプチド |
| CA2732949C (en) * | 2008-08-07 | 2016-12-20 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide |
| ES2574835T3 (es) * | 2008-08-07 | 2016-06-22 | Ipsen Pharma S.A.S. | Análogos del polipéptido insulinotrópico dependiente de glucosa |
| WO2010016936A1 (en) * | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide |
| CN103003300B (zh) * | 2010-04-27 | 2017-06-09 | 西兰制药公司 | Glp‑1受体激动剂和胃泌素的肽缀合物及其用途 |
| CA2872314C (en) * | 2012-05-03 | 2021-08-31 | Zealand Pharma A/S | Gip-glp-1 dual agonist compounds and methods |
| WO2016034186A1 (en) | 2014-09-05 | 2016-03-10 | University Of Copenhagen | Gip peptide analogues |
| US11572399B2 (en) * | 2017-05-31 | 2023-02-07 | University Of Copenhagen | Long-acting GIP peptide analogues |
| TWI912614B (zh) * | 2017-12-21 | 2026-01-21 | 美商美國禮來大藥廠 | 腸促胰島素(incretin)類似物及其用途 |
| US12187773B2 (en) * | 2018-12-03 | 2025-01-07 | Antag Therapeutics Aps | Modified GIP peptide analogues |
-
2020
- 2020-12-03 CN CN202610465590.8A patent/CN122520749A/zh active Pending
- 2020-12-03 AU AU2020398675A patent/AU2020398675A1/en active Pending
- 2020-12-03 IL IL293249A patent/IL293249A/en unknown
- 2020-12-03 JP JP2022532697A patent/JP7788376B2/ja active Active
- 2020-12-03 CA CA3157387A patent/CA3157387A1/en active Pending
- 2020-12-03 WO PCT/EP2020/084487 patent/WO2021110845A1/en not_active Ceased
- 2020-12-03 EP EP20815874.1A patent/EP4069719A1/en active Pending
- 2020-12-03 MX MX2022006737A patent/MX2022006737A/es unknown
- 2020-12-03 US US17/776,976 patent/US20250346647A2/en active Pending
- 2020-12-03 CN CN202080083881.1A patent/CN114761420B/zh active Active
- 2020-12-03 KR KR1020227018518A patent/KR20220108064A/ko active Pending
-
2025
- 2025-08-28 JP JP2025141835A patent/JP2025172864A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250346647A2 (en) | 2025-11-13 |
| MX2022006737A (es) | 2022-06-14 |
| US20230416330A1 (en) | 2023-12-28 |
| JP2023505441A (ja) | 2023-02-09 |
| JP2025172864A (ja) | 2025-11-26 |
| IL293249A (en) | 2022-07-01 |
| CN114761420B (zh) | 2026-04-28 |
| CA3157387A1 (en) | 2021-06-10 |
| JP7788376B2 (ja) | 2025-12-18 |
| KR20220108064A (ko) | 2022-08-02 |
| EP4069719A1 (en) | 2022-10-12 |
| AU2020398675A1 (en) | 2022-05-26 |
| CN114761420A (zh) | 2022-07-15 |
| WO2021110845A1 (en) | 2021-06-10 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication |